KALV- Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palleiko Benjamin L	462.6K	$12.49M	-
Other	Yea Christopher	223.5K	$6.03M	-
Other	Audhya Paul K.	142.5K	$3.85M	-
Other	Arif Bilal	100.0K	$2.70M	-
Other	Sweeny Nicole	51.4K	$1.39M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 11, 2023	Cha Albert	Director	Sale+OE	18,000	$10.50	$189,050.40	-100%	-16.6%	+6.4%
Aug 18, 2023	Audhya Paul K.	Chief Medical Officer	Sale+OE	8,020	$10.73	$86,044.98	-23.6%	-29.4%	+11.3%
Aug 18, 2023	Feener Edward P.72	Chief Scientific Officer	Sale+OE	4,976	$10.73	$53,386.01	-6.4%	-29.4%	+11.3%
Aug 18, 2023	Yea Christopher53	Chief Development Officer	Sale+OE	7,142	$10.73	$76,624.38	-14.6%	-29.4%	+11.3%
Aug 18, 2023	Palleiko Benjamin L46	President, CFO, Cbo &Sec'y	Sale+OE	13,067	$10.73	$140,191.92	-12.1%	-29.4%	+11.3%
Aug 18, 2023	Crockett Thomas Andrew72	CEO	Sale+OE	14,876	$10.73	$159,601.63	-9.2%	-29.4%	+11.3%
May 18, 2023	Yea Christopher53	Chief Development Officer	Sale+OE	2,604	$10.14	$26,416.02	-6.5%	+3.7%	+14.6%
May 18, 2023	Palleiko Benjamin L46	President, CFO, Cbo &Sec'y	Sale+OE	4,037	$10.14	$40,952.94	-4.9%	+3.7%	+14.6%
May 18, 2023	Feener Edward P.72	Chief Scientific Officer	Sale+OE	1,786	$10.14	$18,117.90	-2.6%	+3.7%	+14.6%
May 18, 2023	Crockett Thomas Andrew72	CEO	Sale+OE	5,627	$10.14	$57,082.54	-4.2%	+3.7%	+14.6%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC